Cytotoxic activity induced by Mycobacterium Bovis BCG.
Gheorghiu
M
M
Laboratoire du BCG, Institut Pasteur, Paris, France.
Lagranderie
M
M
Balazuc
A M
AM
Gicquel
B
B
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000284:Administration, Oral; D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use*; D007114:Immunization / Q000379:methods; D007263:Infusions, Parenteral; D051379:Mice; D008807:Mice, Inbred BALB C; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy; D015302:Simian Immunodeficiency Virus; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine